Cerebrospinal Fluid Biomarkers of Neuroinflammation and Neuroplasticity in Type 2 Diabetes Mellitus: Association with Cognitive Performance
Open Access
- 7 August 2026
- journal article
- research article
- Published by MDPI AG in Diabetology
- Vol. 7 (8) , 150
Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is associated with cognitive decline, potentially mediated by neuroinflammatory processes and altered neuroplasticity. This study investigated cerebrospinal fluid (CSF) biomarkers of neuroinflammation and neuroplasticity in T2DM individuals versus controls, and their relationship with cognitive performance. Methods: This cross-sectional study included 56 T2DM individuals and 26 controls (aged 37–70 years; 48% male). CSF concentrations of leptin, IL-6, VEGF, BDNF, TNF-α, IGF-1, and IL-1β were measured using ELISA. Cognitive function was assessed using MMSE, the Stroop test, SDMT, RCFT, and TAAV. Group comparisons used Mann–Whitney U or t-tests; Spearman correlations examined variable relationships. Results: No statistically significant differences in CSF biomarkers were observed between groups. However, T2DM patients showed lower word recall (4.66 ± 1.48 vs. 5.81 ± 1.52; p = 0.002), reduced Symbol–Digit performance (17.82 ± 12.16 vs. 24.92 ± 12.10; p = 0.016), and higher Complex Figure Test scores (19.94 ± 9.32 vs. 15.94 ± 5.02; p = 0.009). IL-6 was negatively correlated with MMSE (r = −0.33, p = 0.005). Significant correlations emerged between MMSE and Symbol–Digit scores (r = 0.40, p < 0.001) and among biomarkers. Conclusions: “No statistically significant differences in CSF biomarkers were observed between groups and unadjusted CSF biomarker concentrations did not differ significantly between groups; however, after adjustment for age and BMI, IL-6 was significantly elevated in T2DM patients, indicating that covariate-adjusted analyses may be more sensitive for detecting subtle neuroinflammatory differences in this population.Keywords
This publication has 42 references indexed in Scilit:
- CSF biomarkers of neuroinflammation are associated with regional atrophyJournal of Neurology, 2025
- Prospective associations of interleukin‐6 and APOE allele with cognitive decline in biracial community‐dwelling older adults: The Chicago Health and Aging Project (CHAP)Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024
- Interleukin-6 trans-signalling in hippocampal CA1 neurones mediates perioperative neurocognitive disorders in miceBritish Journal of Anaesthesia, 2022
- Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studiesAgeing Research Reviews, 2019
- Immune modulation of learning, memory, neural plasticity and neurogenesisBrain, Behavior, and Immunity, 2011
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- Association of C‐reactive protein with mild cognitive impairmentAlzheimer's & Dementia, 2009
- Hypertension and the Risk of Mild Cognitive ImpairmentArchives of Neurology, 2007
- The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's diseaseEuropean Journal of Pharmacology, 2004
- Cognition and synaptic plasticity in diabetes mellitusTrends in Neurosciences, 2000